Literature DB >> 21467229

The association of telomere length and cancer: a meta-analysis.

Ingrid M Wentzensen1, Lisa Mirabello, Ruth M Pfeiffer, Sharon A Savage.   

Abstract

BACKGROUND: Telomeres shorten with each cell division and are essential for chromosomal stability. Short telomeres in surrogate tissues (e.g., blood cells) are associated with increased cancer risk in several case-control studies, but findings are inconsistent in prospective studies.
METHODS: We systematically reviewed studies published prior to August 30, 2010, on the association between telomere length (TL) in surrogate tissues and cancer. There were 27 reports on 13 cancers and/or incident cancer investigating this association. The majority, 16, were retrospective case--control studies, 11 were prospective studies. Meta-analyses were conducted to determine ORs and 95% CIs for these studies.
RESULTS: Studies on bladder, esophageal, gastric, head and neck, ovarian, renal, and overall incident cancer found associations between short telomeres and these cancers. Non-Hodgkin lymphoma, breast, lung, and colorectal cancer reports were inconsistent. Single studies on endometrial, prostate, and skin cancers were null. In a random-effects meta-analysis, short TL was significantly associated with cancer in retrospective studies (pooled OR for the shortest TL quartile compared with the longest: 2.9, 95% CI: 1.75-4.8, P < 0.0001). The pooled OR for prospective studies was 1.16 (95% CI: 0.87-1.54, P = 0.32). All studies combined yielded a pooled OR of 1.96 (95% CI: 1.37-2.81, P = 0.0001) for the association of short TL and cancer. CONCLUSION AND IMPACT: There is suggestive evidence that short surrogate tissue TL is associated with cancer; the strongest evidence exists for bladder, esophageal, gastric, and renal cancers. Additional prospective studies with consistent methodology are needed to confirm this hypothesis. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21467229      PMCID: PMC3111877          DOI: 10.1158/1055-9965.EPI-11-0005

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  63 in total

Review 1.  Short telomeres: cause or consequence of aging?

Authors:  Peter J Hornsby
Journal:  Aging Cell       Date:  2006-11-01       Impact factor: 9.304

2.  Telomere length and genetic analyses in population-based studies of endometrial cancer risk.

Authors:  Jennifer Prescott; Monica McGrath; I-Min Lee; Julie E Buring; Immaculata De Vivo
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860

Review 3.  Cancer in dyskeratosis congenita.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

4.  Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy.

Authors:  J-J Lee; C-E Nam; S-H Cho; K-S Park; I-J Chung; H-J Kim
Journal:  Ann Hematol       Date:  2003-06-21       Impact factor: 3.673

5.  Telomere length in peripheral leukocyte DNA and gastric cancer risk.

Authors:  Lifang Hou; Sharon A Savage; Martin J Blaser; Guillermo Perez-Perez; Mirjam Hoxha; Laura Dioni; Valeria Pegoraro; Linda M Dong; Witold Zatonski; Jolanta Lissowska; Wong-Ho Chow; Andrea Baccarelli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-27       Impact factor: 4.254

6.  Telomere dysfunction: a potential cancer predisposition factor.

Authors:  Xifeng Wu; Christopher I Amos; Yong Zhu; Hua Zhao; Barton H Grossman; Jerry W Shay; Sherry Luo; Waun Ki Hong; Margaret R Spitz
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

Review 7.  Telomeres and aging.

Authors:  Geraldine Aubert; Peter M Lansdorp
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

8.  Leukocyte telomere length predicts cancer risk in Barrett's esophagus.

Authors:  Rosa Ana Risques; Thomas L Vaughan; Xiaohong Li; Robert D Odze; Patricia L Blount; Kamran Ayub; Jasmine L Gallaher; Brian J Reid; Peter S Rabinovitch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-12       Impact factor: 4.254

9.  Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation.

Authors:  C P Schröder; G B Wisman; S de Jong; W T van der Graaf; M H Ruiters; N H Mulder; L F de Leij; A G van der Zee; E G de Vries
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

10.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

View more
  232 in total

1.  Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.

Authors:  Kathryn L Terry; Shelley S Tworoger; Allison F Vitonis; Jason Wong; Linda Titus-Ernstoff; Immaculata De Vivo; Daniel W Cramer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-01-20       Impact factor: 4.254

2.  Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence.

Authors:  Jeffrey N Dock; Rita B Effros
Journal:  Aging Dis       Date:  2011-10       Impact factor: 6.745

3.  Physical activity, sedentary behavior, and leukocyte telomere length in women.

Authors:  Mengmeng Du; Jennifer Prescott; Peter Kraft; Jiali Han; Edward Giovannucci; Susan E Hankinson; Immaculata De Vivo
Journal:  Am J Epidemiol       Date:  2012-02-01       Impact factor: 4.897

4.  Formation of telomeric repeat-containing RNA (TERRA) foci in highly proliferating mouse cerebellar neuronal progenitors and medulloblastoma.

Authors:  Zhong Deng; Zhuo Wang; Chaomei Xiang; Aliah Molczan; Valérie Baubet; Jose Conejo-Garcia; Xiaowei Xu; Paul M Lieberman; Nadia Dahmane
Journal:  J Cell Sci       Date:  2012-05-28       Impact factor: 5.285

Review 5.  Telomere biology: Rationale for diagnostics and therapeutics in cancer.

Authors:  Philippe Rousseau; Chantal Autexier
Journal:  RNA Biol       Date:  2015-08-20       Impact factor: 4.652

6.  Association of mitochondrial DNA copy number in peripheral blood leukocytes with risk of esophageal adenocarcinoma.

Authors:  Enping Xu; Wenjie Sun; Jian Gu; Wong-Ho Chow; Jaffer A Ajani; Xifeng Wu
Journal:  Carcinogenesis       Date:  2013-06-26       Impact factor: 4.944

7.  Telomere length as a risk factor for hereditary prostate cancer.

Authors:  Lauren M Hurwitz; Christopher M Heaphy; Corinne E Joshu; William B Isaacs; Yuko Konishi; Angelo M De Marzo; Sally D Isaacs; Kathy E Wiley; Elizabeth A Platz; Alan K Meeker
Journal:  Prostate       Date:  2013-11-28       Impact factor: 4.104

8.  Associations between circulating sex steroid hormones and leukocyte telomere length in men in the National Health and Nutrition Examination Survey.

Authors:  S B Coburn; B I Graubard; B Trabert; K A McGlynn; M B Cook
Journal:  Andrology       Date:  2018-05-11       Impact factor: 3.842

9.  Telomere length and pancreatic cancer: a case-control study.

Authors:  Halcyon G Skinner; Ronald E Gangnon; Kristin Litzelman; Ruth A Johnson; Suresh T Chari; Gloria M Petersen; Lisa A Boardman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-23       Impact factor: 4.254

10.  Lifespan adversity and later adulthood telomere length in the nationally representative US Health and Retirement Study.

Authors:  Eli Puterman; Alison Gemmill; Deborah Karasek; David Weir; Nancy E Adler; Aric A Prather; Elissa S Epel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.